Aarti Drugs' board to consider shares buyback next week
Aarti Drugs today said its board will meet next week to consider a share buyback proposal.

Aarti Drugs today said its board will meet next week to consider a share buyback proposal.
India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 per cent.
The Union Environment Ministry issued the environment clearance certificate for the proposed project saying that the approval has been given with certain riders.
The government is clearing bottlenecks like environment clearance which the manufacturers are facing in order to give boost to domestic manufacturing of bulk drugs.
FDC is engaged in manufacturing and marketing of APIs and various types of finished formulations like tablets, capsules, granules, oral powders, oral liquids, external powders, creams, ophthalmics, and specialised infant foods.
The Sri Lankan government could also offer sops to Indian firms which invest to expand the production of formulations and bulk drugs there.
These parks will be established on the public private partnership (PPP) mode and the centre is in talks with various states for setting up of these parks.
The Indian bulk drug industry is in dire straits and their prospects appear bleak unless the government takes immediate steps to support them.
"We are importing 70-80 per cent bulk drugs from China. We will shortly come out with strategies to improve our bulk drug capacity in India.